Dr. Fernando Calmet, M.D

NPI: 1659690956
Total Payments
$50,905
2024 Payments
$116.64
Companies
8
Transactions
43
Medicare Patients
3,410
Medicare Billing
$418,277

Payment Breakdown by Category

Other$50,000 (98.2%)
Food & Beverage$802.28 (1.6%)
Travel$102.61 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Grant $50,000 2 98.2%
Food and Beverage $802.28 40 1.6%
Travel and Lodging $102.61 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Boston Scientific Corporation $50,145 5 $0 (2023)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $283.59 13 $0 (2024)
Valeant Pharmaceuticals North America LLC $186.70 8 $0 (2017)
ABBVIE INC. $106.09 5 $0 (2024)
Janssen Biotech, Inc. $102.80 6 $0 (2022)
Gilead Sciences, Inc. $39.86 3 $0 (2018)
Intercept Pharmaceuticals, Inc. $28.33 2 $0 (2018)
Merck Sharp & Dohme Corporation $12.17 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $116.64 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($68.95)
2023 $215.55 6 Boston Scientific Corporation ($145.35)
2022 $78.97 3 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($51.52)
2021 $100.66 5 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($100.66)
2019 $50,021 3 Boston Scientific Corporation ($50,000)
2018 $70.18 5 Intercept Pharmaceuticals, Inc. ($28.33)
2017 $302.24 16 Valeant Pharmaceuticals North America LLC ($186.70)

All Payment Transactions

43 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/13/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.26 General
Category: Gastroenterology
10/16/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $22.14 General
Category: Gastroenterology
10/01/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $22.46 General
Category: IMMUNOLOGY
09/30/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $22.55 General
Category: Gastroenterology
04/11/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $25.23 General
Category: IMMUNOLOGY
12/07/2023 Boston Scientific Corporation ORISE (Device) Food and Beverage In-kind items and services $23.20 General
Category: ORISE_ENDO
12/01/2023 Boston Scientific Corporation Travel and Lodging In-kind items and services $102.61 General
Category: General - Therapies_ENDO
12/01/2023 Boston Scientific Corporation Food and Beverage In-kind items and services $19.54 General
Category: General - Therapies_ENDO
11/01/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.55 General
Category: Gastroenterology
09/20/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $21.96 General
Category: Gastroenterology
03/30/2023 AbbVie Inc. RINVOQ (Biological) Food and Beverage In-kind items and services $23.69 General
Category: IMMUNOLOGY
11/02/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $23.77 General
Category: Gastroenterology
10/13/2022 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $27.45 General
Category: Immunology
03/04/2022 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $27.75 General
Category: Gastroenterology
12/23/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.77 General
Category: Gastroenterology
12/15/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $19.13 General
Category: Gastroenterology
11/12/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.12 General
Category: Gastroenterology
07/14/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.58 General
Category: Gastroenterology
03/08/2021 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $12.06 General
Category: Gastroenterology
12/13/2019 Janssen Biotech, Inc. STELARA (Biological) Food and Beverage In-kind items and services $20.65 General
Category: Immunology
07/24/2019 Boston Scientific Corporation GENERAL BILIARY DEVICES (Device) Grant Cash or cash equivalent $25,000.00 General
Category: BILIARY DEVICES
01/23/2019 Boston Scientific Corporation GENERAL BILIARY DEVICES (Device) Grant Cash or cash equivalent $25,000.00 General
Category: BILIARY DEVICES
04/12/2018 Gilead Sciences, Inc. Food and Beverage In-kind items and services $15.39 General
03/13/2018 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXANIBSD (Drug) Food and Beverage In-kind items and services $15.95 General
Category: GASTROENTEROLOGY
03/08/2018 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $13.35 General
Category: HEPATOLOGY GASTROENTEROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 24 831 915 $1.1M $111,374
2022 25 939 1,054 $1.1M $115,822
2021 23 903 976 $949,851 $106,024
2020 21 737 802 $771,942 $85,057
Total Patients
3,410
Total Services
3,747
Medicare Billing
$418,277
Procedure Codes
95

All Medicare Procedures & Services

95 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare Facility 2023 148 149 $283,100 $31,221 11.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 78 116 $46,292 $12,261 26.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 52 52 $28,774 $6,624 23.0%
43274 Insertion of stent into pancreatic or bile duct using a flexible endoscope Facility 2023 13 16 $48,000 $6,205 12.9%
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 67 71 $106,500 $5,587 5.2%
43264 Removal of stone or debris from bile or pancreatic duct using a flexible endoscope Facility 2023 20 26 $48,204 $4,964 10.3%
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk Facility 2023 26 26 $39,000 $4,872 12.5%
43273 Exam of common bile and/or pancreatic duct using a flexible endoscope Facility 2023 30 40 $80,640 $3,968 4.9%
45390 Removal of large bowel tissue using a flexible endoscope Facility 2023 12 12 $40,800 $3,510 8.6%
43238 Ultrasound guided needle aspiration or biopsy of esophagus using a flexible endoscope Facility 2023 19 19 $39,900 $3,226 8.1%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 44 45 $12,375 $3,156 25.5%
43235 Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope Facility 2023 37 37 $35,631 $3,154 8.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 27 28 $10,500 $2,972 28.3%
45380 Biopsy of large bowel using a flexible endoscope Facility 2023 31 31 $55,800 $2,792 5.0%
43237 Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope through mouth Facility 2023 20 21 $41,979 $2,766 6.6%
45378 Diagnostic exam of large bowel using a flexible endoscope Facility 2023 17 17 $25,500 $2,568 10.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 30 35 $10,630 $2,482 23.3%
43249 Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm Facility 2023 12 13 $37,486 $1,498 4.0%
43262 Incision of pancreatic outlet using a flexible endoscope Facility 2023 26 26 $52,000 $1,299 2.5%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 15 15 $6,005 $1,177 19.6%
91010 Study of esophagus to assess movement Office 2023 20 20 $11,000 $1,089 9.9%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 13 16 $2,873 $1,072 37.3%
74330 Review by radiologist of image from tube placement into bile and pancreatic duct using an endoscope Facility 2023 30 40 $8,000 $939.20 11.7%
91037 Monitoring and recording of esophageal function through nasal tube with electrode Office 2023 20 20 $11,000 $825.00 7.5%
91010 Study of esophagus to assess movement Facility 2023 12 12 $6,600 $653.52 9.9%

About Dr. Fernando Calmet, M.D

Dr. Fernando Calmet, M.D is a Internal Medicine healthcare provider based in Portland, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2010. The National Provider Identifier (NPI) number assigned to this provider is 1659690956.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fernando Calmet, M.D has received a total of $50,905 in payments from pharmaceutical and medical device companies, with $116.64 received in 2024. These payments were reported across 43 transactions from 8 companies. The most common payment nature is "Grant" ($50,000).

As a Medicare-enrolled provider, Calmet has provided services to 3,410 Medicare beneficiaries, totaling 3,747 services with total Medicare billing of $418,277. Data is available for 4 years (2020–2023), covering 95 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Other Specialties Hepatology, Gastroenterology
  • Location Portland, ME
  • Active Since 05/26/2010
  • Last Updated 07/23/2025
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1659690956

Products in Payments

  • GENERAL BILIARY DEVICES (Device) $50,000
  • XIFAXAN (Drug) $454.34
  • STELARA (Biological) $91.44
  • SKYRIZI (Biological) $47.69
  • Humira (Biological) $34.71
  • OCALIVA (Drug) $28.33
  • RINVOQ (Biological) $23.69
  • ORISE (Device) $23.20
  • XIFAXANIBSD (Drug) $15.95
  • DIFICID (Drug) $12.17
  • REMICADE (Biological) $11.36

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Portland